Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual ketamine wafer for breakthrough pain in advanced cancer
ACTRN12621000328875Phase 2Completed
- Sponsor
- Chris O'Brien Lifehouse
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ketamine, sponsored by Chris O'Brien Lifehouse. Started Sep 2021; status: completed.
02
Drugs
ketamine
Beyond the preview
Go deeper on ACTRN12621000328875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000328875.